Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.49
+0.29 (4.68%)
Aug 13, 2025, 4:00 PM - Market closed
Kura Oncology Stock Forecast
Stock Price Forecast
The 11 analysts that cover Kura Oncology stock have a consensus rating of "Strong Buy" and an average price target of $24.45, which forecasts a 276.73% increase in the stock price over the next year. The lowest target is $10 and the highest is $40.
Price Target: $24.45 (+276.73%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kura Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 5 | 5 | 5 | 6 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $28 → $24 | Buy | Maintains | $28 → $24 | +269.80% | Aug 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 26, 2025 |
| Wedbush | Wedbush | Buy Reiterates $36 | Buy | Reiterates | $36 | +454.70% | Jun 20, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +331.43% | Jun 4, 2025 |
| Mizuho | Mizuho | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +362.25% | May 19, 2025 |
Financial Forecast
Revenue This Year
121.26M
from 53.88M
Increased by 125.04%
Revenue Next Year
222.81M
from 121.26M
Increased by 83.75%
EPS This Year
-2.14
from -2.02
EPS Next Year
-2.15
from -2.14
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 235.3M | 473.8M | 396.9M | ||
| Avg | 121.3M | 222.8M | 199.0M | ||
| Low | 16.8M | 31.1M | 55.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 336.7% | 290.7% | 78.1% | ||
| Avg | 125.0% | 83.7% | -10.7% | ||
| Low | -68.9% | -74.4% | -75.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.25 | -0.48 | -0.15 | ||
| Avg | -2.14 | -2.15 | -2.14 | ||
| Low | -3.23 | -4.72 | -4.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.